• 1. Excitable dynamics in the bromate–sulfite–ferrocyanide reaction
  J. Zagora,M. Vosla?,L. Schreiberová,I. Schreiber Phys. Chem. Chem. Phys., 2002,4, 1284-1291
• 2. Excellent energy storage performance in NaNbO3-based relaxor antiferroeic ceramics under a low electric field
  XuxinCheng,XiaomingChen,PengyuanFan
• 3. Elusive 2-aminofuran Diels–Alder substrates for a straightforward synthesis of polysubstituted anilines?
  Ana G. Neo,Ana Bornadiego,Jesús Díaz,Stefano Marcaccini,Carlos F. Marcos Org. Biomol. Chem., 2013,11, 6546-6555
• 4. Distribution and ecological risk assessment of typical antibiotics in the surface waters of seven major rivers, China?
  Environ. Sci.: Processes Impacts, 2021,23, 1088-1100
• 5. Distribution pattern and allocation of defects in hydrogenated ZnO thin films?
  Vitaly Gurylev,Chung-Yi Su,Tsong-Pyng Perng Phys. Chem. Chem. Phys., 2016,18, 16033-16038

Recent Advances in the Application of Methyl 2-amino-4-(trifluoromethyl)pyrimidine-5-carboxylate (CAS: 448242-52-2) in Chemical Biology and Pharmaceutical Research

Methyl 2-amino-4-(trifluoromethyl)pyrimidine-5-carboxylate (CAS: 448242-52-2) is a pyrimidine derivative that has garnered significant attention in recent years due to its versatile applications in chemical biology and pharmaceutical research. This compound serves as a key intermediate in the synthesis of various biologically active molecules, particularly those targeting kinase inhibition and antiviral therapies. Recent studies have highlighted its potential in drug discovery, with a focus on its role in modulating enzymatic activity and its utility in structure-activity relationship (SAR) studies.

One of the most notable advancements in the use of this compound is its incorporation into the development of kinase inhibitors. Kinases play a critical role in cellular signaling pathways, and their dysregulation is often associated with cancer and other diseases. Researchers have utilized Methyl 2-amino-4-(trifluoromethyl)pyrimidine-5-carboxylate as a scaffold to design novel inhibitors with improved selectivity and potency. For instance, a 2023 study published in the Journal of Medicinal Chemistry demonstrated the compound's efficacy in targeting specific tyrosine kinases, leading to promising preclinical results in oncology.

In addition to its role in kinase inhibition, this pyrimidine derivative has shown potential in antiviral research. The trifluoromethyl group enhances the compound's metabolic stability and bioavailability, making it an attractive candidate for antiviral drug development. Recent work has explored its use in the synthesis of nucleoside analogs, which are critical for inhibiting viral replication. A 2022 study in Antiviral Research reported that derivatives of Methyl 2-amino-4-(trifluoromethyl)pyrimidine-5-carboxylate exhibited potent activity against RNA viruses, including SARS-CoV-2, suggesting its relevance in addressing emerging infectious diseases.

The synthetic versatility of Methyl 2-amino-4-(trifluoromethyl)pyrimidine-5-carboxylate has also been a focus of recent research. Advances in green chemistry have enabled more efficient and sustainable methods for its production, reducing the environmental impact of large-scale synthesis. For example, a 2023 publication in Organic Process Research & Development highlighted a novel catalytic process that minimizes waste and improves yield, further enhancing the compound's accessibility for pharmaceutical applications.

Looking ahead, the continued exploration of Methyl 2-amino-4-(trifluoromethyl)pyrimidine-5-carboxylate is expected to yield new insights into its therapeutic potential. Ongoing studies are investigating its use in combination therapies and its ability to target previously undruggable proteins. As the field of chemical biology evolves, this compound is likely to remain a valuable tool for researchers seeking to develop next-generation therapeutics.

• 149771-23-3(2-Amino-4-(trifluoromethyl)pyrimidine-5-carboxylic acid)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)